The Chromogranin A ELISA is a quantitative immunoassay for the determination of CgA in serum and EDTA plasma. 79-30215097 is an update to product code only and replaces product code 72-CGA-EL-US-NG. The kit remains the same.
79-30215097 is available in the United States only. For research use only. Not for use in Diagnostic Procedures.
For the CgA ELISA available outside of the United States, see product code 43-CGAHU-E01.
CGA is a hydrophilic and acidic protein of 439 aa (49 kD) present in the chromaffin granules of neuroendocrine cells. It is part of the
granin family. CGA acts as a pro-hormone. Its proteolysis is a key component of its physiology. This degradation releases biologically
active peptides (vasostatins, chromostatin, pancreastatin, parastatin), which possess different paracrine and autocrine functions. This
proteolysis is tissue-specific and the fragmentation of the protein will be different depending on its location. It primarily takes place in the
cell, inside chromaffin granules.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.
Complement System Solutions for Drug Development and Clinical Research Datasheet
The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.
Melatonin Products for Sleep Disorder-Related Research Datasheet
The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.
